Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
Titel:
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
Auteur:
Hovingh, G Kees Kastelein, John J P van Deventer, Sander J H Round, Patrick Ford, John Saleheen, Danish Rader, Daniel J Brewer, H Bryan Barter, Philip J